Semi-synthetic bile acid could be a promising therapeutic option for TH17-mediated intestinal diseases Post author:admin Post published:March 15, 2025 Post category:uncategorized A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation. You Might Also Like Novel findings on GRB2 and SOS1 could pave the way for cancer treatments October 26, 2024 Finnish study shows 50% reduction in child deaths over 15 years August 30, 2024 Ministers of Health commit to accelerated action against malaria in Africa April 1, 2024